Company intelligence / Profile preview

Bright Eyes

Genoa, Italy

Ownership: Private
Development stage: Other

Overview

BrightEyes is a deep-tech spin-off from the Italian Institute of Technology (IIT) that specializes in advanced optical microscopy solutions. The company develops and commercializes innovative imaging systems based on single-photon detector arrays, which significantly enhance the spatial resolution and sensitivity of traditional laser scanning microscopes. Their core technology allows for super-resolution imaging and fluorescence lifetime measurements without the need for complex hardware modifications or specialized fluorophores. BrightEyes aims to provide researchers in life sciences with accessible, high-performance tools to study biological processes at the nanoscale.

Therapeutic areas: Other
Modalities: Device
Industry: Medical Imaging

Partnerships

Italian Institute of Technology (IIT)European Research Council (ERC)

Beyond the preview

Go deeper on Bright Eyes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bright Eyes.

Explore the full profile